Cargando…

Clinical associations and prognostic value of site-specific metastases in non-small cell lung cancer: A population-based study

The prognosis of non-small cell lung cancer (NSCLC) is poor, particularly for patients with metastatic disease. Numerous efforts have been made to improve the prognosis of these patients; however, only a small number of studies have explored the occurrence rate and prognostic value of different patt...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Zihan, Yang, Qiao, Chen, Xiewan, Zheng, Linpeng, Zhang, Luping, Yu, Yongxin, Chen, Mingjing, You, Qiai, Sun, Jianguo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6507334/
https://www.ncbi.nlm.nih.gov/pubmed/31186781
http://dx.doi.org/10.3892/ol.2019.10225
_version_ 1783417010672107520
author Xu, Zihan
Yang, Qiao
Chen, Xiewan
Zheng, Linpeng
Zhang, Luping
Yu, Yongxin
Chen, Mingjing
You, Qiai
Sun, Jianguo
author_facet Xu, Zihan
Yang, Qiao
Chen, Xiewan
Zheng, Linpeng
Zhang, Luping
Yu, Yongxin
Chen, Mingjing
You, Qiai
Sun, Jianguo
author_sort Xu, Zihan
collection PubMed
description The prognosis of non-small cell lung cancer (NSCLC) is poor, particularly for patients with metastatic disease. Numerous efforts have been made to improve the prognosis of these patients; however, only a small number of studies have explored the occurrence rate and prognostic value of different patterns of distant metastasis (DM) in NSCLC systematically. To investigate these, information from patients diagnosed with NSCLC between 2010 and 2014 was collected from the Surveillance, Epidemiology and End Results database. Survival rate comparisons were performed using Kaplan-Meier analysis and log-rank tests. A Cox proportional hazard model was established to determine factors associated with improved overall survival (OS) and cancer-specific survival (CSS). The present study revealed that the most common site of single metastasis occurrence was bone, and the least common was the liver for NSCLC. As for multi-site metastases, the most common two-site metastasis involved bone and lung, and the most common three-site metastasis involved bone, liver and lung. As for NSCLC subtypes, large cell carcinoma (LCC) exhibited more specific metastatic features. The most common single metastatic site was the brain for patients with LCC, and the most common two-site metastatic combination was bone and liver. Patients with isolated liver metastasis exhibited the worst OS and CSS among patients with single metastasis. Furthermore, for patients with multi-site metastases, metastases involving the liver were associated with the worst OS and CSS among various combinations. To the best of our knowledge, the present study is the first to investigate the occurrence rate and prognostic value of different metastatic patterns of site-specific DM for NSCLC using a large population-based dataset. The findings of the present study may have vital implications for classifying patients with advanced NSCLC, thus laying a foundation for individualized precise treatment.
format Online
Article
Text
id pubmed-6507334
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher D.A. Spandidos
record_format MEDLINE/PubMed
spelling pubmed-65073342019-06-11 Clinical associations and prognostic value of site-specific metastases in non-small cell lung cancer: A population-based study Xu, Zihan Yang, Qiao Chen, Xiewan Zheng, Linpeng Zhang, Luping Yu, Yongxin Chen, Mingjing You, Qiai Sun, Jianguo Oncol Lett Articles The prognosis of non-small cell lung cancer (NSCLC) is poor, particularly for patients with metastatic disease. Numerous efforts have been made to improve the prognosis of these patients; however, only a small number of studies have explored the occurrence rate and prognostic value of different patterns of distant metastasis (DM) in NSCLC systematically. To investigate these, information from patients diagnosed with NSCLC between 2010 and 2014 was collected from the Surveillance, Epidemiology and End Results database. Survival rate comparisons were performed using Kaplan-Meier analysis and log-rank tests. A Cox proportional hazard model was established to determine factors associated with improved overall survival (OS) and cancer-specific survival (CSS). The present study revealed that the most common site of single metastasis occurrence was bone, and the least common was the liver for NSCLC. As for multi-site metastases, the most common two-site metastasis involved bone and lung, and the most common three-site metastasis involved bone, liver and lung. As for NSCLC subtypes, large cell carcinoma (LCC) exhibited more specific metastatic features. The most common single metastatic site was the brain for patients with LCC, and the most common two-site metastatic combination was bone and liver. Patients with isolated liver metastasis exhibited the worst OS and CSS among patients with single metastasis. Furthermore, for patients with multi-site metastases, metastases involving the liver were associated with the worst OS and CSS among various combinations. To the best of our knowledge, the present study is the first to investigate the occurrence rate and prognostic value of different metastatic patterns of site-specific DM for NSCLC using a large population-based dataset. The findings of the present study may have vital implications for classifying patients with advanced NSCLC, thus laying a foundation for individualized precise treatment. D.A. Spandidos 2019-06 2019-04-05 /pmc/articles/PMC6507334/ /pubmed/31186781 http://dx.doi.org/10.3892/ol.2019.10225 Text en Copyright: © Xu et al. This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License (https://creativecommons.org/licenses/by-nc-nd/4.0/) , which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.
spellingShingle Articles
Xu, Zihan
Yang, Qiao
Chen, Xiewan
Zheng, Linpeng
Zhang, Luping
Yu, Yongxin
Chen, Mingjing
You, Qiai
Sun, Jianguo
Clinical associations and prognostic value of site-specific metastases in non-small cell lung cancer: A population-based study
title Clinical associations and prognostic value of site-specific metastases in non-small cell lung cancer: A population-based study
title_full Clinical associations and prognostic value of site-specific metastases in non-small cell lung cancer: A population-based study
title_fullStr Clinical associations and prognostic value of site-specific metastases in non-small cell lung cancer: A population-based study
title_full_unstemmed Clinical associations and prognostic value of site-specific metastases in non-small cell lung cancer: A population-based study
title_short Clinical associations and prognostic value of site-specific metastases in non-small cell lung cancer: A population-based study
title_sort clinical associations and prognostic value of site-specific metastases in non-small cell lung cancer: a population-based study
topic Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6507334/
https://www.ncbi.nlm.nih.gov/pubmed/31186781
http://dx.doi.org/10.3892/ol.2019.10225
work_keys_str_mv AT xuzihan clinicalassociationsandprognosticvalueofsitespecificmetastasesinnonsmallcelllungcancerapopulationbasedstudy
AT yangqiao clinicalassociationsandprognosticvalueofsitespecificmetastasesinnonsmallcelllungcancerapopulationbasedstudy
AT chenxiewan clinicalassociationsandprognosticvalueofsitespecificmetastasesinnonsmallcelllungcancerapopulationbasedstudy
AT zhenglinpeng clinicalassociationsandprognosticvalueofsitespecificmetastasesinnonsmallcelllungcancerapopulationbasedstudy
AT zhangluping clinicalassociationsandprognosticvalueofsitespecificmetastasesinnonsmallcelllungcancerapopulationbasedstudy
AT yuyongxin clinicalassociationsandprognosticvalueofsitespecificmetastasesinnonsmallcelllungcancerapopulationbasedstudy
AT chenmingjing clinicalassociationsandprognosticvalueofsitespecificmetastasesinnonsmallcelllungcancerapopulationbasedstudy
AT youqiai clinicalassociationsandprognosticvalueofsitespecificmetastasesinnonsmallcelllungcancerapopulationbasedstudy
AT sunjianguo clinicalassociationsandprognosticvalueofsitespecificmetastasesinnonsmallcelllungcancerapopulationbasedstudy